COGT Cogent Biosciences, Inc.
Nasdaq · SEC CIK 1622229 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $383.89M 7 sales by 6 insiders
- Filings on record
- 107 since 2021-07-06, latest 2026-08-31 17:01
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Fairmount Funds Management LLC | Dir | — | $370.02M |
| Robinson John Edward | CSO | — | $3.49M |
| Sachs Jessica | Chief Medical Off | — | $3.20M |
| Green John L. | CFO | — | $2.98M |
| Kearns Evan | CLO | — | $2.52M |
| Morris Arlene | Dir | — | $1.69M |
| Pinnow Cole | Chief Commercial Off | — | — |
| Robbins Andrew R | Pres, CEO, Dir | — | — |
Transactions 32
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-08-31 17:01 | 2026-08-27 | COGT | Morris Arlene | Dir | M - OptEx | $5.39 | +45.5K | 45.5K | New | +$245.5K |
| DMT | 2026-08-31 17:01 | 2026-08-27 | COGT | Morris Arlene | Dir | S - Sale+OE | $37.12 | -45.5K | 0 | -100% | -$1.69M |
| 2026-05-21 16:30 | 2026-05-19 | COGT | Robbins Andrew R | Pres, CEO, Dir | G - Gift | $0.00 | -160.0K | 497.5K | -24% | $0 | |
| I | 2026-05-21 16:30 | 2026-05-19 | COGT | Robbins Andrew R | Pres, CEO, Dir | G - Gift | $0.00 | +160.0K | 160.0K | New | $0 |
| DI | 2026-03-31 | 2026-03-31 | COGT | Fairmount Funds Management LLC | Dir | C - Cnv Deriv | — | +7.00M | 12.50M | +127% | — |
| DI | 2026-03-31 | 2026-03-31 | COGT | Fairmount Funds Management LLC | Dir | S - Sale | $34.66 | -7.00M | 5.50M | -56% | -$242.62M |
| I | 2026-01-22 | 2026-01-22 | COGT | Fairmount Funds Management LLC | Dir | S - Sale | $36.40 | -3.50M | 5.50M | -39% | -$127.40M |
| 2025-12-30 | 2025-12-26 | COGT | Kearns Evan | CLO | S - Sale | $38.70 | -65.0K | 109.4K | -37% | -$2.52M | |
| 2025-12-30 | 2025-12-26 | COGT | Robinson John Edward | CSO | S - Sale | $38.74 | -90.0K | 140.0K | -39% | -$3.49M | |
| 2025-12-30 | 2025-12-26 | COGT | Sachs Jessica | Chief Medical Off | S - Sale | $38.70 | -82.6K | 133.9K | -38% | -$3.20M | |
| 2025-12-30 | 2025-12-26 | COGT | Green John L. | CFO | S - Sale | $38.68 | -77.0K | 131.8K | -37% | -$2.98M | |
| DM | 2025-12-19 | 2025-12-17 | COGT | Robinson John Edward | CSO | A - Grant | $0.00 | +370.0K | 370.0K | New | $0 |
| D | 2025-12-19 | 2025-12-17 | COGT | Robinson John Edward | CSO | F - Tax | $39.45 | -140.0K | 230.0K | -38% | -$5.52M |
| D | 2025-12-19 | 2025-12-17 | COGT | Sachs Jessica | Chief Medical Off | F - Tax | $39.45 | -154.7K | 216.6K | -42% | -$6.10M |
| DM | 2025-12-19 | 2025-12-17 | COGT | Sachs Jessica | Chief Medical Off | A - Grant | $0.00 | +370.0K | 51.3K | New | $0 |
| DM | 2025-12-19 | 2025-12-17 | COGT | Kearns Evan | CLO | A - Grant | $0.00 | +300.0K | 300.0K | New | $0 |
| D | 2025-12-19 | 2025-12-17 | COGT | Kearns Evan | CLO | F - Tax | $39.45 | -125.6K | 174.4K | -42% | -$4.95M |
| DM | 2025-12-19 | 2025-12-17 | COGT | Pinnow Cole | Chief Commercial Off | A - Grant | $0.00 | +264.0K | 97.5K | New | $0 |
| D | 2025-12-19 | 2025-12-17 | COGT | Pinnow Cole | Chief Commercial Off | F - Tax | $39.45 | -94.8K | 216.7K | -30% | -$3.74M |
| D | 2025-12-19 | 2025-12-17 | COGT | Green John L. | CFO | F - Tax | $39.45 | -145.0K | 208.8K | -41% | -$5.72M |
| DM | 2025-12-19 | 2025-12-17 | COGT | Green John L. | CFO | A - Grant | $0.00 | +350.0K | 353.8K | +9,112% | $0 |
| D | 2025-12-19 | 2025-12-17 | COGT | Robbins Andrew R | Pres, CEO, Dir | F - Tax | $39.45 | -367.5K | 657.5K | -36% | -$14.50M |
| DM | 2025-12-19 | 2025-12-17 | COGT | Robbins Andrew R | Pres, CEO, Dir | A - Grant | $0.00 | +1.02M | 1.02M | New | $0 |
| I | 2025-07-14 | 2025-07-10 | COGT | Fairmount Funds Management LLC | Dir | P - Purchase | $9.00 | +2.78M | 9.00M | +45% | +$25.00M |
| 2025-01-15 | 2025-01-14 | COGT | Pinnow Cole | Chief Commercial Off | P - Purchase | $7.60 | +43.8K | 45.8K | +2,085% | +$332.5K | |
| DI | 2024-06-12 | 2024-06-10 | COGT | Fairmount Funds Management LLC | Dir | M - OptEx | — | +1.50M | 6.23M | +32% | — |
| DMI | 2024-04-01 | 2024-03-28 | COGT | Fairmount Funds Management LLC | Dir | J - Other | — | 0 | 0 | New | — |
| DI | 2024-02-16 | 2024-02-16 | COGT | Fairmount Funds Management LLC | 10% | A - Grant | $7.50 | +1.17M | 4.44M | +36% | +$8.75M |
| I | 2023-06-13 | 2023-06-09 | COGT | Fairmount Funds Management LLC | 10%, See Remarks | P - Purchase | $12.00 | +800.0K | 3.27M | +32% | +$9.60M |
| 2022-07-01 | 2022-06-30 | COGT | Sachs Jessica | Chief Medical Off | A - Grant | $7.40 | +622 | 622 | New | +$4,603 | |
| I | 2022-06-21 | 2022-06-16 | COGT | Fairmount Funds Management LLC | 10%, See Remarks | P - Purchase | $8.25 | +1.20M | 2.47M | +94% | +$9.90M |
| 2022-01-04 | 2021-12-31 | COGT | Sachs Jessica | Chief Medical Off | A - Grant | $6.82 | +674 | 674 | New | +$4,597 |
Purchase Sale Sale after option exercise All abbreviations